
Biotech Celgene darling of Wall Street
Biotech Celgene is Wall Street analysts top pick for the second half of 2010 after a flurry of upgrades last month made the maker of ……Read More
Biotech Celgene is Wall Street analysts top pick for the second half of 2010 after a flurry of upgrades last month made the maker of ……Read More
Municipalities issued building permits worth $6.0 billion in May, a 10.8% decline from April. The decline follows two consecutive monthly increases. The value of permits in May was 13.9% ……Read More
With volatility and uncertainty elevated, at issue is whether markets are reflecting the equivalent of a pilgrim’s progress or the economic version of the great ……Read More
The Russell 2000 Index, a gauge of the small-cap sector, officially entered a bear market Thursday, dropping more than 20 percent from its intraday high ……Read More
The U.S. stock market is the cheapest since 1951, according to a model comparing earnings valuations to corporate bond yields. The S&P 500 has a ……Read More
The second-half trend for U.S. stocks could be set before July even begins. At about 9 pm ET Wednesday, China will release its purchasing managers ……Read More
© All Rights Reserved. Republish with permission only.